Manage Privacy Preferences
We and our vendors use cookies and similar methods (“Cookies”) to recognize visitors and remember their preferences. We also use Cookies for a variety of purposes, including analytics, to measure marketing effectiveness and to target and measure the effectiveness of ads. You can accept or reject the use of Cookies for individual purposes below. Some vendors process your data on the basis of their legitimate interest - you can object to such processing below. Your preferences will be saved in a cookie named “fides\_consent” for a maximum duration of 12 months, as well as in your registered user account if you are logged in. If you previously accepted these methods through our prior banner, then we will use your data for targeting. Your preferences will apply on nytimes.com, as well as our News, Cooking, Games and Audio apps. Your preferences here are unrelated to Apple’s App Tracking Transparency Framework.
* Purposes
* Features
* Vendors
Below, you will find a list of the purposes and special features for which your data is being processed. You may exercise your rights for specific purposes, based on consent or legitimate interest, using the toggles below.
Below, you will find a list of the features for which your data is being processed. You may exercise your rights for special features using the toggles below.
Below, you will find a list of vendors processing your data and the purposes or features of processing they declare. You may exercise your rights for each vendor based on the legal basis they assert.
SaveReject allAccept all
EnglishEspañol
en
Manage privacy preferences
We and our 341 vendors use cookies and similar methods to store and/or access information on a device and process your personal data (such as unique identifiers and browsing data) for personalised advertising, advertising measurement, audience research and services development, including by using precise geolocation data, and identification through device scanning. To learn more, view our Cookie Policy and Privacy Policy. By clicking ‘Accept all,’ you consent to the processing of your data by us and our vendors on nytimes.com and our News, Cooking, Games, and Audio apps using the above methods. You can always withdraw your consent by clicking on Manage Privacy Preferences in our website footer or in your app Privacy Settings. Your preferences here are unrelated to Apple’s App Tracking Transparency Framework.
We and our partners process data for the following purposes
-----------------------------------------------------------
* Store and/or access information on a device
* Use limited data to select advertising
* Create profiles for personalised advertising
* Use profiles to select personalised advertising
* Measure advertising performance
* Understand audiences through statistics or combinations of data from different sources
* Develop and improve services
* Use precise geolocation data
* Actively scan device characteristics for identification
Manage preferencesReject allAccept all
EnglishEspañol
en
|Faulty Glucose Monitor Sensors May Be Tied to 7 Deaths, F.D.A. Says
The Food and Drug Administration said on Tuesday that people should stop using certain types of glucose monitor sensors after the maker, Abbott Diabetes Care, warned that the faulty products could be tied to at least seven deaths.
About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors may provide incorrect low glucose readings, which could lead people with diabetes to manage the disease incorrectly, according to Abbott Diabetes Care, a division of Abbott Laboratories, a health care company.
The F.D.A. alert applies specifically to sensors that are placed just under the skin and provide real-time measurements of glucose, or sugar, in the blood. Information from the sensor is then transferred wirelessly to a device or phone. The FreeStyle Libre readers and mobile apps are not affected by the issue, the F.D.A. said.
A person who gets an incorrect reading for an extended period, and does not realize, may treat the disease incorrectly, for example by consuming too many carbohydrates or delaying insulin doses. As a result, serious health risks, including injury or death, are possible, according to Abbott Diabetes Care.
There have been 736 reports of injuries, including 57 in the United States, potentially tied to these sensors, Abbott Diabetes Care said in a news release on Nov. 24. The seven deaths were all outside the United States, the company said. These numbers were current as of Thursday, according to Abbott Diabetes Care.
The F.D.A. on Tuesday issued an “early alert,” a warning it provides to the public about potentially high-risk medical device removals or corrections, for the sensors. People who have the affected sensors should immediately stop using them and dispose of them, the agency said.
Abbott Diabetes Care estimated that about half of the affected sensors have been used or expired. The company said owners of FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors could go to a website, freestylecheck.com, or call the company’s customer service number, 1-833-815-4273, to check the serial numbers to see if their sensors are affected and to get a free replacement. The F.D.A. also provided a list of the more than 750 affected lots of sensors.
The faulty sensors were made on one production line, according to Abbott Diabetes Care, adding that the cause of the problem, which the company did not specify, had been identified and resolved. The company said it would continue to make new sensors and did not expect any “significant” supply disruptions.
Amanda Holpuch covers breaking news and other topics.
See more on: Abbott Laboratories
Related Content
---------------